TP53 and diffuse large B-cell lymphoma: This comprehensive study evaluated 664 DLBCL cases to: (1) assess NGS detection ability for TP53 copy number losses (CNLs) and (2) investigate the diagnostic efficiency of p53 immunohistochemistry (IHC) as a potential surrogate marker for TP53 genetic alterations.